[Argentine consensus of non-invasive ventilation].
Non-invasive ventilation (NIV) is nowadays increasingly used. The significant decrease in tracheal intubation related complications makes it particularly attractive in patients with moderately acute respiratory failure (ARF) who still have some degree of respiratory autonomy. It has also been used to support patients with chronic respiratory failure. However, final outcomes are variable according to the conditions which determined its application. This Consensus was performed in order to review the evidence supporting the use of positive pressure NIV. The patho-physiological background of NIV and the equipment required technology are described. Available evidence clearly suggests benefits of NIV in acute exacerbation of chronic obstructive pulmonary disease (COPD) and in cardiogenic pulmonary edema (Recommendation A). When considering ARF in the setting of acute respiratory distress syndrome results are uncertain, unless dealing with immunosupressed patients (Recommendation B). Positive results are also shown in weaning of mechanical ventilation (MV), particularly regarding acute exacerbation of COPD patients (Recommendation A). An improved quality of life in chronic respiratory failure and a longer survival in restrictive disorders has also been shown (Recommendation B) while its benefit in stable COPD patients is still controversial (Recommendation C). NIV should be performed according to pre-established standards. A revision of NIV related complications is performed and the cost-benefit comparison with invasive MV is also considered.
Diez
Ana R
AR
Sección Neumonología Crítica, Asociación Argentina de Medicina Respiratoria (AAMR). vorodiez@fibertel.com.ar
Abbona
Horacio
H
Ferrero
Gerardo
G
Figueroa Casas
Juan C
JC
De Vega
Marcelino
M
Lisanti
Raul
R
Lopez
Ana M
AM
Menga
Guillermo
G
Montiel
Guillermo C
GC
Perez Chada
Daniel
D
Raimondi
Alejandro C
AC
Raimondi
Guillermo A
GA
Uribe Echevarria
María Elisa
ME
Vázquez
Walter D
WD
D000208:Acute Disease; D001118:Argentina; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy; D012121:Respiration, Artificial / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D012131:Respiratory Insufficiency / Q000503:physiopathology / Q000628:therapy*; D015300:Ventilator Weaning / Q000592:standards; D012122:Ventilators, Mechanical / Q000592:standards